Depression in schizophrenia: Recognition and management in the USA
Depression in schizophrenia: Recognition and management in the USA
复制标题
DOI：
10.1016/s0920-9964(00)00135-3
复制
发表时间：
2001-03-01
影响因子：
4.5
通讯作者：
Hirsch, SR
中科院分区：
文献类型：
--
作者：
Siris, SG;Addington, D;Hirsch, SR
将抑郁症作为精神分裂症中的一种独特综合征的认识是一个相对较新的发展。国际精神分裂症抑郁调查旨在评估精神分裂症抑郁部分管理的当前临床实践和处方趋势。向37 513名精神科医生分发了一份48项问卷，包括固定回答问题和由病例情景刺激的问题。美国共有43 484名精神科医生，澳大利亚和21个欧洲国家也收到了调查问卷。共有1128名美国精神科医生做出了回应。对数据的分析显示，美国精神科医生：在大约三分之一的精神分裂症患者中发现了抑郁症状，并在很大程度上意识到了由此给患者及其家庭带来的负担。关于治疗方法和情况下的问题的回答表明，在美国的抗抑郁药的连续性处方的水平往往高于其他regions.Level的精神分裂症患者的抑郁症的认识和认识到需要有效的管理似乎是高的美国精神科医生。然而，超过四分之一的专家很少或从不开抗抑郁药。差异：与现有科学证据基础不同的治疗方法强调需要进一步研究优化这种严重共存疾病的管理方法。(C)2001 Elsevier Science B.V.保留所有权利。
The recognition of depression as a distinct syndrome within schizophrenia is a relatively recent development. The International Survey of Depression in Schizophrenia was designed to evaluate current clinical practice and prescribing trends in the management of the depressive component of schizophrenia.A 48-item questionnaire, comprising fixed-response questions and questions stimulated by case scenarios, was distributed to 37 513 psychiatrists in the USA.A total of 43 484 psychiatrists in Canada, Australia and 21 European countries also received the questionnaire. A total of 1128 US psychiatrists responded. Analysis of the data revealed that US psychiatrists: identify symptoms of depression in approximately one-third of patients with schizophrenia, and largely appreciate the magnitude of the resultant burden on patients and their families. Responses to questions regarding treatment approaches and case scenarios demonstrated that the level of adjunctive prescribing of antidepressants in the USA is often higher than in other regions.Levels of awareness of depression in patients with schizophrenia and recognition of the need for effective management appear to be high among US psychiatrists. However, more than a quarter of these specialists rarely or never prescribe adjunctive antidepressant medications. Disparities: in treatment approaches varying from the existing scientific evidence base underscore the need for further investigation into ways: of optimizing the management of this serious coexisting condition. (C) 2001 Elsevier Science B.V. All rights reserved.